Helsinn is committed to increasing awareness of MF-CTCL and the importance of early diagnosis, so patients get the help they need.
Privacy Policy | Terms & Conditions
This site is intended for US Healthcare Professionals only
© 2022 Helsinn Therapeutics (U.S.), Inc. All rights reserved. V-HELS-US-0273 1221